Cargando…

Inadvertent Methylergonovine Administration to a Neonate

Patient: Male, Newborn Final Diagnosis: Accidental methylergonovine poisoning Symptoms: Respiratory distress Medication: — Clinical Procedure: — Specialty: Pediatrics and Neonatology OBJECTIVE: Diagnostic/therapeutic accidents BACKGROUND: Methylergonovine is an ergot alkaloid used to treat post-part...

Descripción completa

Detalles Bibliográficos
Autores principales: Corbett, Bryan M., O’Connell, Charles, Boutin, Mallory A., Fatayerji, Nabil I., Sauer, Charles W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077293/
https://www.ncbi.nlm.nih.gov/pubmed/27765939
http://dx.doi.org/10.12659/AJCR.900263
_version_ 1782462155549835264
author Corbett, Bryan M.
O’Connell, Charles
Boutin, Mallory A.
Fatayerji, Nabil I.
Sauer, Charles W.
author_facet Corbett, Bryan M.
O’Connell, Charles
Boutin, Mallory A.
Fatayerji, Nabil I.
Sauer, Charles W.
author_sort Corbett, Bryan M.
collection PubMed
description Patient: Male, Newborn Final Diagnosis: Accidental methylergonovine poisoning Symptoms: Respiratory distress Medication: — Clinical Procedure: — Specialty: Pediatrics and Neonatology OBJECTIVE: Diagnostic/therapeutic accidents BACKGROUND: Methylergonovine is an ergot alkaloid used to treat post-partum hemorrhage secondary to uterine atony. Mistaking methylergonovine for vitamin K with accidental administration to the neonate is a rare iatrogenic illness occurring almost exclusively in the delivery room setting. Complications of ergot alkaloids in neonates include respiratory depression, seizures, and death. CASE REPORT: A term infant was inadvertently given 0.1 mg of methylergonovine intramuscularly in the right thigh. The error was only noted when the vial of medication was scanned, after administration, identifying it as methylergonovine rather than vitamin K. The local poison center was notified, and the infant was transferred to the neonatal intensive care unit for observation. Two hours after transfer, the infant was noted to have oxygen desaturations and required oxygen via nasal cannula. Supplemental oxygen was continued for 4 hours until the neonate was able to maintain normal oxygen saturations in room air. Feeding was started by 10 hours of life, and the infant was discharged home in good condition after a 72-hour stay without further complications. CONCLUSIONS: Because of the potential for serious adverse events, vigilance is required to prevent accidental administration of methylergonovine to the neonate as a result of possible confusion with vitamin K in the early post-partum period.
format Online
Article
Text
id pubmed-5077293
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-50772932016-11-01 Inadvertent Methylergonovine Administration to a Neonate Corbett, Bryan M. O’Connell, Charles Boutin, Mallory A. Fatayerji, Nabil I. Sauer, Charles W. Am J Case Rep Articles Patient: Male, Newborn Final Diagnosis: Accidental methylergonovine poisoning Symptoms: Respiratory distress Medication: — Clinical Procedure: — Specialty: Pediatrics and Neonatology OBJECTIVE: Diagnostic/therapeutic accidents BACKGROUND: Methylergonovine is an ergot alkaloid used to treat post-partum hemorrhage secondary to uterine atony. Mistaking methylergonovine for vitamin K with accidental administration to the neonate is a rare iatrogenic illness occurring almost exclusively in the delivery room setting. Complications of ergot alkaloids in neonates include respiratory depression, seizures, and death. CASE REPORT: A term infant was inadvertently given 0.1 mg of methylergonovine intramuscularly in the right thigh. The error was only noted when the vial of medication was scanned, after administration, identifying it as methylergonovine rather than vitamin K. The local poison center was notified, and the infant was transferred to the neonatal intensive care unit for observation. Two hours after transfer, the infant was noted to have oxygen desaturations and required oxygen via nasal cannula. Supplemental oxygen was continued for 4 hours until the neonate was able to maintain normal oxygen saturations in room air. Feeding was started by 10 hours of life, and the infant was discharged home in good condition after a 72-hour stay without further complications. CONCLUSIONS: Because of the potential for serious adverse events, vigilance is required to prevent accidental administration of methylergonovine to the neonate as a result of possible confusion with vitamin K in the early post-partum period. International Scientific Literature, Inc. 2016-10-21 /pmc/articles/PMC5077293/ /pubmed/27765939 http://dx.doi.org/10.12659/AJCR.900263 Text en © Am J Case Rep, 2016 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
spellingShingle Articles
Corbett, Bryan M.
O’Connell, Charles
Boutin, Mallory A.
Fatayerji, Nabil I.
Sauer, Charles W.
Inadvertent Methylergonovine Administration to a Neonate
title Inadvertent Methylergonovine Administration to a Neonate
title_full Inadvertent Methylergonovine Administration to a Neonate
title_fullStr Inadvertent Methylergonovine Administration to a Neonate
title_full_unstemmed Inadvertent Methylergonovine Administration to a Neonate
title_short Inadvertent Methylergonovine Administration to a Neonate
title_sort inadvertent methylergonovine administration to a neonate
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077293/
https://www.ncbi.nlm.nih.gov/pubmed/27765939
http://dx.doi.org/10.12659/AJCR.900263
work_keys_str_mv AT corbettbryanm inadvertentmethylergonovineadministrationtoaneonate
AT oconnellcharles inadvertentmethylergonovineadministrationtoaneonate
AT boutinmallorya inadvertentmethylergonovineadministrationtoaneonate
AT fatayerjinabili inadvertentmethylergonovineadministrationtoaneonate
AT sauercharlesw inadvertentmethylergonovineadministrationtoaneonate